Bleier; Benjamin S.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Bleier; Benjamin S..The latest application filed is for "methods and compositions to treat and diagnose diseases or pathologies associated with inflammation of the sinuses and nasal cavity".

Company Profile

3.10.15

Bleier; Benjamin S. - Weston MA
BLEIER; Benjamin S. - Boston MA
Bleier; Benjamin S. - Villanova PA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Secreted P-glycoprotein is a non-invasive biomarker of chronic rhinosinusitis Grant 11,408,900 - Bleier , et al. August 9, 2	2022-08-09
Methods and Compositions to Treat and Diagnose Diseases or Pathologies Associated with Inflammation of the Sinuses and Nasal Cavity App 20220168260 - Bleier; Benjamin S.	2022-06-02
Biodegradable Implant for Sustained Trans-Nasal Delivery of Therapeutic Agents to the Brain App 20210378947 - AMIJI; Mansoor M. ; et al.	2021-12-09
Treatment of Rhinosinusitis with P-glycoprotein Inhibitors App 20210330737 - Bleier; Benjamin S.	2021-10-28
Treatment of rhinosinusitis with P-glycoprotein inhibitors Grant 11,007,246 - Bleier May 18, 2	2021-05-18
Submucosal Drug Delivery Apparatuses, Systems, And Methods App 20210023295 - Bleier; Benjamin S.	2021-01-28
Treatment of Rhinosinusitis with P-glycoprotein Inhibitors App 20200197481 - Bleier; Benjamin S.	2020-06-25
Treatment of rhinosinusitis with P-glycoprotein inhibitors Grant 10,653,745 - Bleier	2020-05-19
Secreted P-glycoprotein is a Non-Invasive Biomarker of Chronic Rhinosinusitis App 20190086426 - Bleier; Benjamin S. ; et al.	2019-03-21
Treatment of Rhinosinusitis with P-glycoprotein Inhibitors App 20170348384 - Bleier; Benjamin S.	2017-12-07
Treatment of rhinosinusitis with P-glycoprotein inhibitors Grant 9,744,210 - Bleier August 29, 2	2017-08-29
Methods of delivering pharmaceutical agents Grant 9,517,200 - Bleier December 13, 2	2016-12-13
Methods of delivering pharmaceutical agents Grant 9,439,852 - Bleier September 13, 2	2016-09-13
Methods of Delivering Pharmaceutical Agents App 20160193145 - Bleier; Benjamin S.	2016-07-07
Treatment of Rhinosinusitis with P-glycoprotein Inhibitors App 20160193286 - Bleier; Benjamin S.	2016-07-07
Methods Of Delivering Pharmaceutical Agents App 20150283071 - Bleier; Benjamin S.	2015-10-08
Methods of delivering pharmaceutical agents Grant 9,084,756 - Bleier July 21, 2	2015-07-21
Methods Of Delivering Pharmaceutical Agents App 20150119324 - Bleier; Benjamin S.	2015-04-30
Methods of delivering pharmaceutical agents Grant 8,945,600 - Bleier February 3, 2	2015-02-03
Methods Of Delivering Pharmaceutical Agents App 20140256627 - Bleier; Benjamin S.	2014-09-11
Methods of delivering pharmaceutical agents Grant 8,673,338 - Bleier March 18, 2	2014-03-18
Methods Of Delivering Pharmaceutical Agents App 20130030056 - Bleier; Benjamin S.	2013-01-31
Solder Formulation And Use In Tissue Welding App 20110172704 - Bleier; Benjamin S. ; et al.	2011-07-14

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.